MX2010005860A - Adenovirus simianos de la subfamilia c sadv-40, sadv-31 y sadv-34 y usos de los mismos. - Google Patents
Adenovirus simianos de la subfamilia c sadv-40, sadv-31 y sadv-34 y usos de los mismos.Info
- Publication number
- MX2010005860A MX2010005860A MX2010005860A MX2010005860A MX2010005860A MX 2010005860 A MX2010005860 A MX 2010005860A MX 2010005860 A MX2010005860 A MX 2010005860A MX 2010005860 A MX2010005860 A MX 2010005860A MX 2010005860 A MX2010005860 A MX 2010005860A
- Authority
- MX
- Mexico
- Prior art keywords
- sadv
- simian
- subfamily
- adenoviruses
- adenoviruses sadv
- Prior art date
Links
- 241000701161 unidentified adenovirus Species 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 241000990167 unclassified Simian adenoviruses Species 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 230000001105 regulatory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Un vector recombinante comprende secuencias SAdV-40, SAdV31 o SAdV-34 de adenovirus simiano y un gen heterólogo bajo el control de secuencias reguladoras; una línea celular la cual expresa el gen(es) de adenovirus simiano SAdV-40, SAdV-31 o SAdV-34 también es descrita; métodos para usar los vectores y líneas celulares también son proporcionados.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US449607P | 2007-11-28 | 2007-11-28 | |
US446507P | 2007-11-28 | 2007-11-28 | |
US456807P | 2007-11-28 | 2007-11-28 | |
PCT/US2008/013067 WO2009105084A2 (en) | 2007-11-28 | 2008-11-24 | Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010005860A true MX2010005860A (es) | 2010-06-22 |
Family
ID=40933501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010005860A MX2010005860A (es) | 2007-11-28 | 2008-11-24 | Adenovirus simianos de la subfamilia c sadv-40, sadv-31 y sadv-34 y usos de los mismos. |
Country Status (11)
Country | Link |
---|---|
US (1) | US8231880B2 (es) |
EP (2) | EP2220217A2 (es) |
JP (2) | JP5758124B2 (es) |
KR (1) | KR101614369B1 (es) |
CN (1) | CN102131920B (es) |
AU (1) | AU2008350937B2 (es) |
BR (1) | BRPI0819774A2 (es) |
CA (1) | CA2707029A1 (es) |
MX (1) | MX2010005860A (es) |
WO (1) | WO2009105084A2 (es) |
ZA (1) | ZA201003895B (es) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0822651A2 (pt) | 2007-11-28 | 2014-10-14 | Univ Pennsylvania | Subfamília b de adenovírus sadv-28, -27, 29, -32, -33 e -35 de símio e seus usos |
CN101883858B (zh) | 2007-11-28 | 2015-07-22 | 宾夕法尼亚大学托管会 | 猿猴亚家族E腺病毒SAdV-39、-25.2、-26、-30、-37和-38及其应用 |
MX2010005860A (es) | 2007-11-28 | 2010-06-22 | Univ Pennsylvania | Adenovirus simianos de la subfamilia c sadv-40, sadv-31 y sadv-34 y usos de los mismos. |
CN102016011B (zh) | 2008-03-04 | 2013-12-11 | 宾夕法尼亚大学托管会 | 猿猴腺病毒sadv-36、-42.1、-42.2和-44及其应用 |
US8940290B2 (en) | 2008-10-31 | 2015-01-27 | The Trustees Of The University Of Pennsylvania | Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50 and uses thereof |
ES2898235T3 (es) | 2009-02-02 | 2022-03-04 | Glaxosmithkline Biologicals Sa | Secuencias de aminoácidos y de ácidos nucleicos de adenovirus de simio, vectores que las contienen, y sus usos |
EP2435559A1 (en) | 2009-05-29 | 2012-04-04 | The Trustees Of The University Of Pennsylvania | Simian adenovirus 41 and uses thereof |
AU2011332025B2 (en) | 2010-11-23 | 2015-06-25 | The Trustees Of The University Of Pennsylvania | Subfamily E simian adenoviruses A1321, A1325, A1295, A1309 and A1322 and uses thereof |
TWI575070B (zh) | 2011-07-12 | 2017-03-21 | 傳斯堅公司 | Hbv聚合酶突變體 |
WO2013045658A1 (en) | 2011-09-29 | 2013-04-04 | Transgene Sa | Immunotherapy composition and regimen for treating hepatitis c virus infection |
WO2013045668A2 (en) | 2011-09-29 | 2013-04-04 | Transgene Sa | Immunotherapy composition and regimen for treating hepatitis c virus infection |
AU2013262626B2 (en) | 2012-05-18 | 2018-11-29 | The Trustees Of The University Of Pennsylvania | Subfamily E simian adenoviruses A1302, A1320, A1331 and A1337 and uses thereof |
EP2971008B1 (en) | 2013-03-14 | 2018-07-25 | Salk Institute for Biological Studies | Oncolytic adenovirus compositions |
WO2015188165A1 (en) * | 2014-06-06 | 2015-12-10 | The Regents Of The University Of California | Self-shielded, benchtop chemistry system |
US10577627B2 (en) | 2014-06-09 | 2020-03-03 | Voyager Therapeutics, Inc. | Chimeric capsids |
WO2016057387A1 (en) | 2014-10-06 | 2016-04-14 | The Trustees Of The University Of Pennsylvania | Compositions and methods for isolation of circulating tumor cells (ctc) |
CA2966620A1 (en) | 2014-11-05 | 2016-05-12 | Voyager Therapeutics, Inc. | Aadc polynucleotides for the treatment of parkinson's disease |
US10597660B2 (en) | 2014-11-14 | 2020-03-24 | Voyager Therapeutics, Inc. | Compositions and methods of treating amyotrophic lateral sclerosis (ALS) |
SG11201703419UA (en) | 2014-11-14 | 2017-05-30 | Voyager Therapeutics Inc | Modulatory polynucleotides |
US11697825B2 (en) | 2014-12-12 | 2023-07-11 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scAAV |
WO2016131945A1 (en) | 2015-02-20 | 2016-08-25 | Transgene Sa | Combination product with autophagy modulator |
GB201514772D0 (en) * | 2015-08-19 | 2015-09-30 | Glaxosmithkline Biolog Sa | Adenovirus polynucleotides and polypeptides |
BE1024824B1 (fr) * | 2015-06-12 | 2018-07-13 | Glaxosmithkline Biologicals Sa | Polynucleotides et polypeptides d'adenovirus |
CN107921118B (zh) * | 2015-06-12 | 2022-11-08 | 葛兰素史密丝克莱恩生物有限公司 | 腺病毒多核苷酸和多肽 |
GB201513176D0 (en) * | 2015-07-27 | 2015-09-09 | Glaxosmithkline Biolog Sa | Novel methods for inducing an immune response |
WO2017096162A1 (en) | 2015-12-02 | 2017-06-08 | Voyager Therapeutics, Inc. | Assays for the detection of aav neutralizing antibodies |
WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
KR102471633B1 (ko) | 2016-02-23 | 2022-11-25 | 솔크 인스티튜트 포 바이올로지칼 스터디즈 | 바이러스 동역학에 미치는 영향 최소화를 위한 치료용 아데노바이러스의 외인성 유전자 발현 |
WO2017189964A2 (en) | 2016-04-29 | 2017-11-02 | Voyager Therapeutics, Inc. | Compositions for the treatment of disease |
EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
US20190134190A1 (en) | 2016-05-04 | 2019-05-09 | Transgene Sa | Combination therapy with cpg tlr9 ligand |
KR102392236B1 (ko) | 2016-05-18 | 2022-05-03 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
SG11201809643UA (en) | 2016-05-18 | 2018-12-28 | Voyager Therapeutics Inc | Compositions and methods of treating huntington's disease |
US11298041B2 (en) | 2016-08-30 | 2022-04-12 | The Regents Of The University Of California | Methods for biomedical targeting and delivery and devices and systems for practicing the same |
US20190328869A1 (en) | 2016-10-10 | 2019-10-31 | Transgene Sa | Immunotherapeutic product and mdsc modulator combination therapy |
GB201620968D0 (en) * | 2016-12-09 | 2017-01-25 | Glaxosmithkline Biologicals Sa | Adenovirus polynucleotides and polypeptides |
EP3551644B1 (en) * | 2016-12-09 | 2023-08-16 | GlaxoSmithKline Biologicals SA | Chimpanzee adenovirus constructs with lyssavirus antigens |
CN110062630A (zh) | 2016-12-12 | 2019-07-26 | 萨克生物研究学院 | 肿瘤靶向合成腺病毒及其用途 |
WO2018204803A1 (en) | 2017-05-05 | 2018-11-08 | Voyager Therapeutics, Inc. | Compositions and methods of treating huntington's disease |
CN110913866A (zh) | 2017-05-05 | 2020-03-24 | 沃雅戈治疗公司 | 治疗肌萎缩性侧索硬化(als)的组合物和方法 |
JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
WO2019018342A1 (en) | 2017-07-17 | 2019-01-24 | Voyager Therapeutics, Inc. | NETWORK EQUIPMENT TRACK GUIDE SYSTEM |
JP7221275B2 (ja) | 2017-08-03 | 2023-02-13 | ボイジャー セラピューティクス インコーポレイテッド | Aavを送達するための組成物および方法 |
JP7502991B2 (ja) | 2017-10-16 | 2024-06-19 | ボイジャー セラピューティクス インコーポレイテッド | 筋萎縮性側索硬化症(als)の治療 |
WO2019079242A1 (en) | 2017-10-16 | 2019-04-25 | Voyager Therapeutics, Inc. | TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) |
BR112020007695A2 (pt) * | 2017-10-31 | 2020-10-20 | Janssen Vaccines & Prevention B.V. | adenovírus e seus usos |
EP3807404A1 (en) | 2018-06-13 | 2021-04-21 | Voyager Therapeutics, Inc. | Engineered 5' untranslated regions (5' utr) for aav production |
CN112770812A (zh) | 2018-07-24 | 2021-05-07 | 沃雅戈治疗公司 | 产生基因治疗制剂的***和方法 |
TW202035689A (zh) | 2018-10-04 | 2020-10-01 | 美商航海家醫療公司 | 測量病毒載體粒子的效價及強度之方法 |
CN113166731A (zh) | 2018-10-05 | 2021-07-23 | 沃雅戈治疗公司 | 编码aav生产蛋白的工程化核酸构建体 |
EP3867389A1 (en) | 2018-10-15 | 2021-08-25 | Voyager Therapeutics, Inc. | Expression vectors for large-scale production of raav in the baculovirus/sf9 system |
CN113924115A (zh) | 2019-01-31 | 2022-01-11 | 俄勒冈健康与科学大学 | 用于aav衣壳的使用转录依赖性定向进化的方法 |
US20230256057A1 (en) | 2020-07-13 | 2023-08-17 | Transgene | Treatment of immune depression |
CA3209779A1 (en) | 2021-02-01 | 2022-08-04 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
WO2022218997A1 (en) | 2021-04-12 | 2022-10-20 | Centre National De La Recherche Scientifique (Cnrs) | Novel universal vaccine presenting system |
KR20240036508A (ko) * | 2021-05-13 | 2024-03-20 | 포지 바이올로직스, 인크. | 아데노바이러스성 헬퍼 플라스미드 |
WO2023213764A1 (en) | 2022-05-02 | 2023-11-09 | Transgene | Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
US5240846A (en) | 1989-08-22 | 1993-08-31 | The Regents Of The University Of Michigan | Gene therapy vector for cystic fibrosis |
US6174666B1 (en) | 1992-03-27 | 2001-01-16 | The United States Of America As Represented By The Department Of Health And Human Services | Method of eliminating inhibitory/instability regions from mRNA |
EP0804076A4 (en) | 1994-10-19 | 1998-10-21 | Genetic Therapy Inc | GENTHERAPY THROUGH SIMULTANEOUS AND REPEATED ADMINISTRATION OF ADENOVIRUS AND IMMUNE SUPPRESSIVES |
US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
PT787200E (pt) | 1994-10-28 | 2005-08-31 | Univ Pennsylvania | Adenovirus melhorado e metodos para a sua utilizacao |
WO1996026285A2 (en) | 1995-02-24 | 1996-08-29 | The Trustees Of The University Of Pennsylvania | Methods and compositions for administering gene therapy vectors |
AU4255397A (en) | 1996-09-06 | 1998-03-26 | Trustees Of The University Of Pennsylvania, The | Chimpanzee adenovirus vectors |
WO1998010088A1 (en) | 1996-09-06 | 1998-03-12 | Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
US5922315A (en) | 1997-01-24 | 1999-07-13 | Genetic Therapy, Inc. | Adenoviruses having altered hexon proteins |
US5891994A (en) | 1997-07-11 | 1999-04-06 | Thymon L.L.C. | Methods and compositions for impairing multiplication of HIV-1 |
EP1015619A1 (en) | 1997-09-19 | 2000-07-05 | The Trustees Of The University Of Pennsylvania | Methods and cell line useful for production of recombinant adeno-associated viruses |
WO1999014354A1 (en) | 1997-09-19 | 1999-03-25 | The Trustees Of The University Of The Pennsylvania | Methods and vector constructs useful for production of recombinant aav |
GB9720585D0 (en) | 1997-09-26 | 1997-11-26 | Smithkline Beecham Biolog | Vaccine |
WO1999029334A1 (en) | 1997-12-12 | 1999-06-17 | Saint Louis University | CtIP, A NOVEL PROTEIN THAT INTERACTS WITH CtBP AND USES THEREFOR |
JP2002506652A (ja) | 1998-03-20 | 2002-03-05 | トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 組換えアデノ随伴ウイルスのヘルパーを含まない製造のための組成物及び方法 |
AU5677399A (en) | 1998-08-20 | 2000-03-14 | Wistar Institute Of Anatomy And Biology, The | Methods of augmenting mucosal immunity through systemic priming and mucosal boosting |
US6258595B1 (en) | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
AP2002002592A0 (en) | 2000-01-31 | 2002-09-30 | Smithkline Beecham Biolog | Vaccine for the prophylactic or therapeutic immunization against HIV. |
AU2001234981A1 (en) | 2000-02-09 | 2001-08-20 | Genvec, Inc. | Adenoviral capsid containing chimeric protein ix |
US7344872B2 (en) | 2001-06-22 | 2008-03-18 | The Trustees Of The University Of Pennsylvania | Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
US20040136963A1 (en) | 2001-06-22 | 2004-07-15 | The Trustees Of The University Of Pennsylvania | Simian adenovirus vectors and methods of use |
CN1167801C (zh) * | 2001-10-25 | 2004-09-22 | 山西德元堂药业有限公司 | 重组人vegf腺病毒载体及其应用 |
NZ550416A (en) | 2001-11-21 | 2008-06-30 | Univ Pennsylvania | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
CN100475966C (zh) * | 2001-11-23 | 2009-04-08 | 上海三维生物技术有限公司 | 具有肿瘤细胞特异性感染和转基因表达能力的新型腺病毒 |
US7491508B2 (en) | 2003-06-20 | 2009-02-17 | The Trustees Of The University Of Pennsylvania | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
US7291498B2 (en) | 2003-06-20 | 2007-11-06 | The Trustees Of The University Of Pennsylvania | Methods of generating chimeric adenoviruses and uses for such chimeric adenoviruses |
ATE449105T1 (de) * | 2004-01-23 | 2009-12-15 | Angeletti P Ist Richerche Bio | Impfstoffträger für schimpansen-adenovirus |
DE602007004470D1 (de) | 2006-04-28 | 2010-03-11 | Univ Pennsylvania | Modifiziertes adenovirus-hexon-protein und anwendungen davon |
MX2010005860A (es) | 2007-11-28 | 2010-06-22 | Univ Pennsylvania | Adenovirus simianos de la subfamilia c sadv-40, sadv-31 y sadv-34 y usos de los mismos. |
CN101883858B (zh) | 2007-11-28 | 2015-07-22 | 宾夕法尼亚大学托管会 | 猿猴亚家族E腺病毒SAdV-39、-25.2、-26、-30、-37和-38及其应用 |
-
2008
- 2008-11-24 MX MX2010005860A patent/MX2010005860A/es active IP Right Grant
- 2008-11-24 BR BRPI0819774-1A2A patent/BRPI0819774A2/pt not_active Application Discontinuation
- 2008-11-24 EP EP08872541A patent/EP2220217A2/en not_active Withdrawn
- 2008-11-24 CA CA2707029A patent/CA2707029A1/en not_active Abandoned
- 2008-11-24 JP JP2010535988A patent/JP5758124B2/ja not_active Expired - Fee Related
- 2008-11-24 WO PCT/US2008/013067 patent/WO2009105084A2/en active Application Filing
- 2008-11-24 CN CN2008801185826A patent/CN102131920B/zh not_active Expired - Fee Related
- 2008-11-24 AU AU2008350937A patent/AU2008350937B2/en not_active Ceased
- 2008-11-24 US US12/744,405 patent/US8231880B2/en active Active
- 2008-11-24 KR KR1020107014133A patent/KR101614369B1/ko not_active IP Right Cessation
- 2008-11-24 EP EP12158503.8A patent/EP2463362B1/en not_active Not-in-force
-
2010
- 2010-06-01 ZA ZA2010/03895A patent/ZA201003895B/en unknown
-
2014
- 2014-12-05 JP JP2014246771A patent/JP2015083007A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2011504751A (ja) | 2011-02-17 |
JP5758124B2 (ja) | 2015-08-05 |
WO2009105084A2 (en) | 2009-08-27 |
AU2008350937A1 (en) | 2009-08-27 |
EP2463362A1 (en) | 2012-06-13 |
BRPI0819774A2 (pt) | 2014-10-14 |
US8231880B2 (en) | 2012-07-31 |
EP2463362B1 (en) | 2017-11-08 |
JP2015083007A (ja) | 2015-04-30 |
WO2009105084A8 (en) | 2010-10-07 |
AU2008350937B2 (en) | 2014-10-09 |
US20100260799A1 (en) | 2010-10-14 |
CN102131920B (zh) | 2013-11-06 |
KR101614369B1 (ko) | 2016-04-21 |
CN102131920A (zh) | 2011-07-20 |
EP2220217A2 (en) | 2010-08-25 |
ZA201003895B (en) | 2011-04-28 |
CA2707029A1 (en) | 2009-08-27 |
WO2009105084A3 (en) | 2009-12-30 |
KR20100105630A (ko) | 2010-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010005860A (es) | Adenovirus simianos de la subfamilia c sadv-40, sadv-31 y sadv-34 y usos de los mismos. | |
WO2012071318A3 (en) | Subfamily e simian adenoviruses a1321, a1325, a1295, a1309, a1316 and a1322 and uses thereof | |
MX2010005858A (es) | Adenovirus e simianos sadv-39, sadv-25.2, sadv-26, sadv-30, sadv-37 y sadv-38. | |
WO2009136977A3 (en) | Simian adenoviruses sadv-36,-42.1, -42.2, and -44 and uses thereof | |
MX2014014024A (es) | Adenovirus de simio de la subfamilia e a1302, a1320, a1331 y a1337 y sus usos. | |
MX344106B (es) | Adenovirus simianos de la subfamilia b sadv-28, sadv-29, sadv-32, sadv-33 y sadv-35 y usos de los mismos. | |
SG165153A1 (en) | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use | |
MX2010003319A (es) | Vacunas y componentes de vacunas para inhibicion de celulas microbianas. | |
MX2010003369A (es) | Regiones no traducidas 5' sinteticas, vectores de expresion y metodos para incrementar la expresion transgenica. | |
WO2008122811A3 (en) | Adenoviral vectors encoding a pathogen or tumour antigen | |
IN2014DN03061A (es) | ||
IN2014DN03005A (es) | ||
NZ628213A (en) | Adenoviruses expressing heterologous tumor-associated antigens | |
MX2019006725A (es) | Polinucleotidos y polipeptidos de adenovirus. | |
MX2018005399A (es) | Nuevo polipeptido con afinidad por pd-l1. | |
MY166156A (en) | Mooring system and connector assembly | |
EP2558481A4 (en) | FROM APE-ADENOVIRUS SEROTYPE 19 ISOLATED HEXON, HYPERVARIABLE REGION THEREOF AND CHIMERIC ADENOVIRUS THEREOF | |
WO2011084647A3 (en) | Toxin-immunity system | |
EP3878513A4 (en) | GENE THERAPY USING SINGLE AAV VECTOR GENOEDITTING | |
MX2020013553A (es) | Polinucleotidos y polipeptidos de adenovirus. | |
WO2007087478A8 (en) | Linear vectors, host cells and cloning methods | |
WO2007134325A3 (en) | Methods and compositions for protein production using adenoviral vectors | |
MX2009000898A (es) | Metodos y composiciones para aumentar el tropismo en tejido de vectores adenovirales recombinantes. | |
AU2019204711A1 (en) | Securely performing cryptographic operations | |
WO2005010149A3 (en) | Subgroup b adenoviral vectors for treating disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |